Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary, as always on Thursday, focuses on the general market update. For the week the XBI was down -0.7% and now sits at +10.3% year-to-date. This week confirmed the playbook. Biotech can rally and capital can return quickly, but funding is flowing to companies with clean catalysts a…
Substack is the home for great culture